Ignite Creation Date:
2024-05-05 @ 11:45 AM
Last Modification Date:
2024-10-26 @ 9:13 AM
Study NCT ID:
NCT00126542
Status:
COMPLETED
Last Update Posted:
2014-05-14
First Post:
2005-08-02
Brief Title:
Bevacizumab and Erlotinib in Treating Patients With Recurrent or Metastatic Ovarian Epithelial Fallopian Tube or Primary Peritoneal Cavity Cancer
Sponsor:
National Cancer Institute NCI
Organization:
National Cancer Institute NCI
Key Dates - Follows AllAPIJSON File Order
Start Date:
2005-04
Start Date Type:
None
Primary Completion Date:
2007-01
Primary Completion Date Type:
ACTUAL
Completion Date:
2010-04
Completion Date Type:
ACTUAL
First Submit Date:
2005-08-02
First Submit QC Date:
August 2 2005
Study First Post Date:
2005-08-04
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2014-05-13
Last Update Post Date:
2014-05-14
Last Update Post Date Type:
ESTIMATED